文献速递创面修复

King分级III级糖尿病足溃疡门诊患者治疗反应与合并症的预测因素

The Predictive Factors Associated With Comorbidities for Treatment Response in Outpatients With King Classification III Diabetes Foot Ulcers.
PubMed 文献 · Ann Plast Surg · 2018-01-01

前瞻性研究纳入2011年1月至12月在嘉义长庚纪念医院门诊治疗的100例King分级III级糖尿病足溃疡患者,随访至少1年。按治疗反应分为成功组70例、停滞组22例和失败组8例;既往经皮腔内血管成形术史与治疗失败强相关(OR 14.33,95%CI 1.71-120.32,P=0.014),视网膜病变是治疗成功的主要负向预测因素(OR 0.21,95%CI 0.07-0.65,P=0.006)。

要点

  • 既往经皮腔内血管成形术史是King III级糖尿病足溃疡治疗失败的预测因素(OR 14.33)。
  • 视网膜病变是治疗成功的主要负向预测因素(OR 0.21,95%CI 0.07-0.65)。
  • 视网膜病变在治疗停滞组发生率为42.1%,高于失败组14.3%和成功组12.5%(P=0.019)。

核心结论

  • 既往经皮腔内血管成形术和视网膜病变分别提示既存的严重血管病变,是King分级III级糖尿病足溃疡患者治疗失败和治疗不成功的单变量预测因素。

研究设计与样本

  • 前瞻性研究纳入2011年1月至12月在嘉义长庚纪念医院门诊治疗的100例King分级III级糖尿病足溃疡患者,最短随访时间为1年。

主要发现

  • 按治疗反应三组分层:失败组8例、停滞组22例、成功组70例;视网膜病变发生率在停滞组为42.1%,高于失败组14.3%和成功组12.5%(P=0.019)。
  • 按治疗反应三组分层:既往经皮腔内血管成形术史比例在失败组为25%,高于停滞组4.8%和成功组1.5%(P=0.020)。
  • 失败组8例 vs 非失败组92例:既往经皮腔内血管成形术史与治疗失败强相关(OR 14.33,95%CI 1.71-120.32,P=0.014)。
  • 成功组70例 vs 非成功组30例:视网膜病变是治疗成功的主要负向预测因素(OR 0.21,95%CI 0.07-0.65,P=0.006)。
  • 既往清创术预测治疗不成功达临界显著性(OR 0.09,95%CI 0.01-1.01,P=0.051)。

临床怎么用

  • 作者认为,对King分级III级糖尿病足溃疡进行细分后,病史采集和眼底检查是门诊风险筛查可接受的方法。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The aim of this study is to investigate the preexisting predictive factors associated with comorbidities for diabetic foot ulcer (DFU) in King classification III at an outpatient clinic. METHOD: This prospective study included 100 patients with DFU in King classification III treated at outpatient clinics in Chiayi Chang Gung Memorial Hospital from January 2011 to December 2011. The least follow-up time was 1 year. Medical documentations were in respect of patient's baseline characteristics, associated history, presence of comorbidities, follow-up time, and condition of wounds. Patients were divided into success group (healed or healing with wound reduction), stagnate group, and failure group (amputation or infection, need in-hospital medical service) in accordance with the treatment response of wounds. χ Test, Fisher exact test, and 1-way analysis of variance were used for variables in 3-group comparison, whereas Student t test was applied in 2-group comparison. The predictive factors with P value less than 0.1 were further investigated using the model of univariate logistic regression. RESULTS: With 3-group stratification according to treatment response-failure (n = 8), stagnate (n = 22), and success (n = 70)-the occurrence rate of retinopathy was higher in the treatment stagnate group (42.1%) than in the treatment failure (14.3%) and success groups (12.5%; P = 0.019); the rate of previous percutaneous transluminal angioplasty (PTA) history was higher in the treatment failure group (25%) than in the treatment stagnate (4.8%) and success groups (1.5%; P = 0.020). With 2-group stratification-failure (n = 8) versus nonfailure (n = 92), and success (n = 70) versus nonsuccess (n = 30)-PTA history was strongly associated with treatment failure (odds ratio [OR], 14.33; 95% confidence interval [CI], 1.71-120.32; P = 0.014), whereas retinopathy (OR, 0.21; 95% CI, 0.07-0.65; P = 0.006) was the major negative predictor for treatment success. Previous debridement met borderline significance to predict treatment nonsuccess (OR, 0.09; 95% CI, 0.01-1.01; P = 0.051). Sex, age, associated history, dyslipidemia, hypertension, coronary artery disease, cerebrovascular accident, chronic kidney disease, and end-stage renal disease and wound condition had no statistical significance. CONCLUSIONS: Previous PTA and retinopathy, which indicated preexisting severe vasculopathy, are univariate predictive factors for treatment failure and nonsuccess, respectively, in patients with King classification III DFU. With the subdivision of King classification III DFU, medical history taking and fundus examination are acceptable methods for risk screening at an outpatient clinic.

来源:Ann Plast Surg,查看原文。版权归原作者所有。

引用

  1. Su CL, Chang CC, Peng YS, et al. The Predictive Factors Associated With Comorbidities for Treatment Response in Outpatients With King Classification III Diabetes Foot Ulcers. Ann Plast Surg. 2018. PMID: 29851722. doi:10.1097/SAP.0000000000001500

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。